Clinical Trials Browser

Phase NA × Neoplasm, Residual × Lymphoid × Clear all

NCT07517705 2026-04-08

MRD-Adapted Low-Dose Radiation Therapy During Frontline Chemoimmunotherapy for Diffuse Large B-Cell Lymphoma

Phase NA Not yet recruiting

50 enrolled

Lymphoid

Lymphoma, Large B-Cell, Diffuse, Neoplasm, Residual

NCT07443592 2026-03-02

LAL-2025

Phase NA Not yet recruiting

330 enrolled

LymphoidOther hematologic neoplasm

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06693830 2026-01-23

ctDNA-guided Therapy Optimization in Newly Diagnosed DLBCL

Phase NA Recruiting

40 enrolled

Lymphoid

Lymphoma, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Neoplasm, Residual

NCT06744075 2025-12-30

CELERITY

Phase NA Active not recruiting

108 enrolled

Lymphoid

Hodgkin Disease, Lymphoma, Lymphoma, B-Cell, Neoplasm, Residual

NCT07003737 2025-06-04

Blinatumomab Intensification for MRD-Negative Acute B-Cell Lymphoblastic Leukemia Before Allogeneic Hematopoietic Stem Cell Transplantation

Phase NA Recruiting

114 enrolled

LymphoidOther hematologic neoplasm

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05093192 2023-09-08

Mobilising Tumour and Immune Cells Via Exercise in Chronic Lymphocytic Leukaemia

Phase NA Completed

26 enrolled

LymphoidOther hematologic neoplasm

Motor Activity, Leukemia, Lymphocytic, Chronic, B-Cell, Neoplasm, Residual

NCT04179929 2022-02-18

Treatment of Breakpoint Cluster Region-Abelson (BCR-ABL) Negative ALL in Adults

Phase NA Recruiting

300 enrolled

LymphoidOther hematologic neoplasm

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03564977 2018-07-02

CD19-targeted CAR-T Cell Therapy for MRD+ B-cell Malignancies After Autologous Stem Cell Transplantation

Phase NA Unknown

20 enrolled

LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Lymphoma, B-Cell, Neoplasm, Residual

NCT02339805 2017-07-07

LymphoSeq

Phase NA Completed

30 enrolled

Lymphoid

Lymphoma, Non-Hodgkin, Neoplasm, Residual